Clinical value of a high-fat and low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis
We hypothesized that a high-fat and low-carbohydrate (HFLC) diet before FDG-PET/CT could identify patients with active cardiac sarcoidosis (CS). Fifty-eight sarcoidosis patients with a suspicion of CS consumed a HFLC diet before FDG-PET/CT. Clinical, electrical, and other imaging investigations were...
Gespeichert in:
| Veröffentlicht in: | Journal of nuclear cardiology 2013-02, Vol.20 (1), p.120-127 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 127 |
|---|---|
| container_issue | 1 |
| container_start_page | 120 |
| container_title | Journal of nuclear cardiology |
| container_volume | 20 |
| creator | Soussan, Michael Brillet, Pierre-Yves Nunes, Hilario Pop, Gabriel Ouvrier, Matthieu-John Naggara, Nicolas Valeyre, Dominique Weinmann, Pierre |
| description | We hypothesized that a high-fat and low-carbohydrate (HFLC) diet before FDG-PET/CT could identify patients with active cardiac sarcoidosis (CS).
Fifty-eight sarcoidosis patients with a suspicion of CS consumed a HFLC diet before FDG-PET/CT. Clinical, electrical, and other imaging investigations were compared to PET results.
Using Japanese Ministry of Health and Welfare (JMHW) criteria as a gold standard, 21% (12/58) of patients had a CS. Sensitivity and specificity of PET (visual analysis) were 83% (10/12) and 78% (36/46), respectively, with a very good interobserver agreement (k = 0.86). 70% (7/10) of the patients with a positive PET and negative JMHW criteria exhibited abnormalities suggestive of CS either on MR (n = 3) or SPECT (n = 4). Comparison with the presence of delayed enhancement on magnetic resonance imaging helped to classify patients with active (PET positive) or non-active CS (PET negative). In addition, when MR and PET were both negative, none of the patients met the JMHW criteria. PET response under treatment was concordant with clinical evolution in 11/13 patients.
FDG-PET/CT after HFLC diet is a sensitive tool for the diagnosis of active CS. Combined use of PET and MR is promising for the detection and characterization of CS lesions. |
| doi_str_mv | 10.1007/s12350-012-9653-3 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1273704944</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1071358123032439</els_id><sourcerecordid>1273704944</sourcerecordid><originalsourceid>FETCH-LOGICAL-c424t-91a051712da6e74b796d08afd2baedf7d10401b92db060f0964e5d267f1256703</originalsourceid><addsrcrecordid>eNp9kc1u1DAUhSMEoqXwAGyQJTZs3N5rJ_FErND0D6lSuxjWlmPfdFxl4sFOWvUFeG4cpaCqi3rja_k7x9Y5RfEZ4RgB1ElCISvggII3dSW5fFMcYiUFr6sK3-YZFHJZrfCg-JDSHQA0smneFwdC4mpVC3VY_Fn3fvDW9Oze9BOx0DHDtv52yzszMjM41ocHbk1sw_bRRTMSc55G1lIXIrHz0wt-c7Y5WW9YPjOaTczowzAb7fNEw5jYgx-3LE1pT3Ykx7Kb88ayZKIN3oXk08fiXWf6RJ-e9qPi1_nZZn3Jr64vfq5_XHFbinLkDRqoUKFwpiZVtqqpHaxM50RryHXKIZSAbSNcCzV00NQlVU7UqkNR1QrkUfFt8d3H8HuiNOqdT5b63gwUpqRRKKmgbMoyo19foHdhikP-3Uzl_DCvTOFC2RhSitTpffQ7Ex81gp5L0ktJOpek55K0zJovT85TuyP3X_GvlQyIBUj5aril-OzpV1y_LyLK-d37LEo2x2_J-Zhz1y74V9R_ATtorzQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1271881111</pqid></control><display><type>article</type><title>Clinical value of a high-fat and low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Soussan, Michael ; Brillet, Pierre-Yves ; Nunes, Hilario ; Pop, Gabriel ; Ouvrier, Matthieu-John ; Naggara, Nicolas ; Valeyre, Dominique ; Weinmann, Pierre</creator><creatorcontrib>Soussan, Michael ; Brillet, Pierre-Yves ; Nunes, Hilario ; Pop, Gabriel ; Ouvrier, Matthieu-John ; Naggara, Nicolas ; Valeyre, Dominique ; Weinmann, Pierre</creatorcontrib><description>We hypothesized that a high-fat and low-carbohydrate (HFLC) diet before FDG-PET/CT could identify patients with active cardiac sarcoidosis (CS).
Fifty-eight sarcoidosis patients with a suspicion of CS consumed a HFLC diet before FDG-PET/CT. Clinical, electrical, and other imaging investigations were compared to PET results.
Using Japanese Ministry of Health and Welfare (JMHW) criteria as a gold standard, 21% (12/58) of patients had a CS. Sensitivity and specificity of PET (visual analysis) were 83% (10/12) and 78% (36/46), respectively, with a very good interobserver agreement (k = 0.86). 70% (7/10) of the patients with a positive PET and negative JMHW criteria exhibited abnormalities suggestive of CS either on MR (n = 3) or SPECT (n = 4). Comparison with the presence of delayed enhancement on magnetic resonance imaging helped to classify patients with active (PET positive) or non-active CS (PET negative). In addition, when MR and PET were both negative, none of the patients met the JMHW criteria. PET response under treatment was concordant with clinical evolution in 11/13 patients.
FDG-PET/CT after HFLC diet is a sensitive tool for the diagnosis of active CS. Combined use of PET and MR is promising for the detection and characterization of CS lesions.</description><identifier>ISSN: 1071-3581</identifier><identifier>EISSN: 1532-6551</identifier><identifier>DOI: 10.1007/s12350-012-9653-3</identifier><identifier>PMID: 23188627</identifier><language>eng</language><publisher>Boston: Elsevier Inc</publisher><subject>Aged ; Cardiology ; Diet, Carbohydrate-Restricted ; Diet, High-Fat ; Dietary Carbohydrates - metabolism ; Female ; fluorodeoxyglucose (FDG) ; Fluorodeoxyglucose F18 ; Humans ; Imaging ; Magnetic Resonance Imaging ; Male ; Medicine ; Medicine & Public Health ; Middle Aged ; Monitoring, Ambulatory ; Myocarditis ; Myocarditis - diagnostic imaging ; Nuclear Medicine ; Original Article ; PET/CT imaging ; Positron-Emission Tomography - methods ; Radiology ; Radiopharmaceuticals ; Sarcoidosis - diagnostic imaging ; Tomography, X-Ray Computed - methods</subject><ispartof>Journal of nuclear cardiology, 2013-02, Vol.20 (1), p.120-127</ispartof><rights>2013 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved.</rights><rights>American Society of Nuclear Cardiology 2012</rights><rights>American Society of Nuclear Cardiology 2013</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c424t-91a051712da6e74b796d08afd2baedf7d10401b92db060f0964e5d267f1256703</citedby><cites>FETCH-LOGICAL-c424t-91a051712da6e74b796d08afd2baedf7d10401b92db060f0964e5d267f1256703</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12350-012-9653-3$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12350-012-9653-3$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51298</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23188627$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Soussan, Michael</creatorcontrib><creatorcontrib>Brillet, Pierre-Yves</creatorcontrib><creatorcontrib>Nunes, Hilario</creatorcontrib><creatorcontrib>Pop, Gabriel</creatorcontrib><creatorcontrib>Ouvrier, Matthieu-John</creatorcontrib><creatorcontrib>Naggara, Nicolas</creatorcontrib><creatorcontrib>Valeyre, Dominique</creatorcontrib><creatorcontrib>Weinmann, Pierre</creatorcontrib><title>Clinical value of a high-fat and low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis</title><title>Journal of nuclear cardiology</title><addtitle>J. Nucl. Cardiol</addtitle><addtitle>J Nucl Cardiol</addtitle><description>We hypothesized that a high-fat and low-carbohydrate (HFLC) diet before FDG-PET/CT could identify patients with active cardiac sarcoidosis (CS).
Fifty-eight sarcoidosis patients with a suspicion of CS consumed a HFLC diet before FDG-PET/CT. Clinical, electrical, and other imaging investigations were compared to PET results.
Using Japanese Ministry of Health and Welfare (JMHW) criteria as a gold standard, 21% (12/58) of patients had a CS. Sensitivity and specificity of PET (visual analysis) were 83% (10/12) and 78% (36/46), respectively, with a very good interobserver agreement (k = 0.86). 70% (7/10) of the patients with a positive PET and negative JMHW criteria exhibited abnormalities suggestive of CS either on MR (n = 3) or SPECT (n = 4). Comparison with the presence of delayed enhancement on magnetic resonance imaging helped to classify patients with active (PET positive) or non-active CS (PET negative). In addition, when MR and PET were both negative, none of the patients met the JMHW criteria. PET response under treatment was concordant with clinical evolution in 11/13 patients.
FDG-PET/CT after HFLC diet is a sensitive tool for the diagnosis of active CS. Combined use of PET and MR is promising for the detection and characterization of CS lesions.</description><subject>Aged</subject><subject>Cardiology</subject><subject>Diet, Carbohydrate-Restricted</subject><subject>Diet, High-Fat</subject><subject>Dietary Carbohydrates - metabolism</subject><subject>Female</subject><subject>fluorodeoxyglucose (FDG)</subject><subject>Fluorodeoxyglucose F18</subject><subject>Humans</subject><subject>Imaging</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Monitoring, Ambulatory</subject><subject>Myocarditis</subject><subject>Myocarditis - diagnostic imaging</subject><subject>Nuclear Medicine</subject><subject>Original Article</subject><subject>PET/CT imaging</subject><subject>Positron-Emission Tomography - methods</subject><subject>Radiology</subject><subject>Radiopharmaceuticals</subject><subject>Sarcoidosis - diagnostic imaging</subject><subject>Tomography, X-Ray Computed - methods</subject><issn>1071-3581</issn><issn>1532-6551</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kc1u1DAUhSMEoqXwAGyQJTZs3N5rJ_FErND0D6lSuxjWlmPfdFxl4sFOWvUFeG4cpaCqi3rja_k7x9Y5RfEZ4RgB1ElCISvggII3dSW5fFMcYiUFr6sK3-YZFHJZrfCg-JDSHQA0smneFwdC4mpVC3VY_Fn3fvDW9Oze9BOx0DHDtv52yzszMjM41ocHbk1sw_bRRTMSc55G1lIXIrHz0wt-c7Y5WW9YPjOaTczowzAb7fNEw5jYgx-3LE1pT3Ykx7Kb88ayZKIN3oXk08fiXWf6RJ-e9qPi1_nZZn3Jr64vfq5_XHFbinLkDRqoUKFwpiZVtqqpHaxM50RryHXKIZSAbSNcCzV00NQlVU7UqkNR1QrkUfFt8d3H8HuiNOqdT5b63gwUpqRRKKmgbMoyo19foHdhikP-3Uzl_DCvTOFC2RhSitTpffQ7Ex81gp5L0ktJOpek55K0zJovT85TuyP3X_GvlQyIBUj5aril-OzpV1y_LyLK-d37LEo2x2_J-Zhz1y74V9R_ATtorzQ</recordid><startdate>20130201</startdate><enddate>20130201</enddate><creator>Soussan, Michael</creator><creator>Brillet, Pierre-Yves</creator><creator>Nunes, Hilario</creator><creator>Pop, Gabriel</creator><creator>Ouvrier, Matthieu-John</creator><creator>Naggara, Nicolas</creator><creator>Valeyre, Dominique</creator><creator>Weinmann, Pierre</creator><general>Elsevier Inc</general><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20130201</creationdate><title>Clinical value of a high-fat and low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis</title><author>Soussan, Michael ; Brillet, Pierre-Yves ; Nunes, Hilario ; Pop, Gabriel ; Ouvrier, Matthieu-John ; Naggara, Nicolas ; Valeyre, Dominique ; Weinmann, Pierre</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c424t-91a051712da6e74b796d08afd2baedf7d10401b92db060f0964e5d267f1256703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Aged</topic><topic>Cardiology</topic><topic>Diet, Carbohydrate-Restricted</topic><topic>Diet, High-Fat</topic><topic>Dietary Carbohydrates - metabolism</topic><topic>Female</topic><topic>fluorodeoxyglucose (FDG)</topic><topic>Fluorodeoxyglucose F18</topic><topic>Humans</topic><topic>Imaging</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Monitoring, Ambulatory</topic><topic>Myocarditis</topic><topic>Myocarditis - diagnostic imaging</topic><topic>Nuclear Medicine</topic><topic>Original Article</topic><topic>PET/CT imaging</topic><topic>Positron-Emission Tomography - methods</topic><topic>Radiology</topic><topic>Radiopharmaceuticals</topic><topic>Sarcoidosis - diagnostic imaging</topic><topic>Tomography, X-Ray Computed - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Soussan, Michael</creatorcontrib><creatorcontrib>Brillet, Pierre-Yves</creatorcontrib><creatorcontrib>Nunes, Hilario</creatorcontrib><creatorcontrib>Pop, Gabriel</creatorcontrib><creatorcontrib>Ouvrier, Matthieu-John</creatorcontrib><creatorcontrib>Naggara, Nicolas</creatorcontrib><creatorcontrib>Valeyre, Dominique</creatorcontrib><creatorcontrib>Weinmann, Pierre</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of nuclear cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Soussan, Michael</au><au>Brillet, Pierre-Yves</au><au>Nunes, Hilario</au><au>Pop, Gabriel</au><au>Ouvrier, Matthieu-John</au><au>Naggara, Nicolas</au><au>Valeyre, Dominique</au><au>Weinmann, Pierre</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical value of a high-fat and low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis</atitle><jtitle>Journal of nuclear cardiology</jtitle><stitle>J. Nucl. Cardiol</stitle><addtitle>J Nucl Cardiol</addtitle><date>2013-02-01</date><risdate>2013</risdate><volume>20</volume><issue>1</issue><spage>120</spage><epage>127</epage><pages>120-127</pages><issn>1071-3581</issn><eissn>1532-6551</eissn><abstract>We hypothesized that a high-fat and low-carbohydrate (HFLC) diet before FDG-PET/CT could identify patients with active cardiac sarcoidosis (CS).
Fifty-eight sarcoidosis patients with a suspicion of CS consumed a HFLC diet before FDG-PET/CT. Clinical, electrical, and other imaging investigations were compared to PET results.
Using Japanese Ministry of Health and Welfare (JMHW) criteria as a gold standard, 21% (12/58) of patients had a CS. Sensitivity and specificity of PET (visual analysis) were 83% (10/12) and 78% (36/46), respectively, with a very good interobserver agreement (k = 0.86). 70% (7/10) of the patients with a positive PET and negative JMHW criteria exhibited abnormalities suggestive of CS either on MR (n = 3) or SPECT (n = 4). Comparison with the presence of delayed enhancement on magnetic resonance imaging helped to classify patients with active (PET positive) or non-active CS (PET negative). In addition, when MR and PET were both negative, none of the patients met the JMHW criteria. PET response under treatment was concordant with clinical evolution in 11/13 patients.
FDG-PET/CT after HFLC diet is a sensitive tool for the diagnosis of active CS. Combined use of PET and MR is promising for the detection and characterization of CS lesions.</abstract><cop>Boston</cop><pub>Elsevier Inc</pub><pmid>23188627</pmid><doi>10.1007/s12350-012-9653-3</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1071-3581 |
| ispartof | Journal of nuclear cardiology, 2013-02, Vol.20 (1), p.120-127 |
| issn | 1071-3581 1532-6551 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1273704944 |
| source | MEDLINE; Springer Nature - Complete Springer Journals |
| subjects | Aged Cardiology Diet, Carbohydrate-Restricted Diet, High-Fat Dietary Carbohydrates - metabolism Female fluorodeoxyglucose (FDG) Fluorodeoxyglucose F18 Humans Imaging Magnetic Resonance Imaging Male Medicine Medicine & Public Health Middle Aged Monitoring, Ambulatory Myocarditis Myocarditis - diagnostic imaging Nuclear Medicine Original Article PET/CT imaging Positron-Emission Tomography - methods Radiology Radiopharmaceuticals Sarcoidosis - diagnostic imaging Tomography, X-Ray Computed - methods |
| title | Clinical value of a high-fat and low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T09%3A40%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20value%20of%20a%20high-fat%20and%20low-carbohydrate%20diet%20before%20FDG-PET/CT%20for%20evaluation%20of%20patients%20with%20suspected%20cardiac%20sarcoidosis&rft.jtitle=Journal%20of%20nuclear%20cardiology&rft.au=Soussan,%20Michael&rft.date=2013-02-01&rft.volume=20&rft.issue=1&rft.spage=120&rft.epage=127&rft.pages=120-127&rft.issn=1071-3581&rft.eissn=1532-6551&rft_id=info:doi/10.1007/s12350-012-9653-3&rft_dat=%3Cproquest_cross%3E1273704944%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1271881111&rft_id=info:pmid/23188627&rft_els_id=S1071358123032439&rfr_iscdi=true |